Better diagnostics. Better patient outcomes.
Identify infection and predict clarithromycin resistance with one specimen
Helicobacter pylori, or H. pylori, is one of the most common chronic bacterial infections in the world. As the main cause of peptic ulcer disease and a major risk factor for gastric cancer, H. pylori can lead to life-threatening medical conditions if left untreated. Timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm. Due to the rising prevalence of antimicrobial resistance, however, understanding who to test and how to select the best treatment for H. pylori poses clinical challenges for health care providers.
Mayo Clinic Laboratories now offers a noninvasive option for the molecular detection of H. pylori using a single fecal specimen. This test:
HPFRP | Helicobacter pylori with Clarithromycin Resistance Prediction, Molecular Detection, PCR, Feces
Additional H. pylori testing available from Mayo Clinic Laboratories